Ristau J

Title : FAP imaging in rare cancer entities-first clinical experience in a broad spectrum of malignancies - Dendl_2022_Eur.J.Nucl.Med.Mol.Imaging_49_721

Author(s) : Dendl K , Finck R , Giesel FL , Kratochwil C , Lindner T , Mier W , Cardinale J , Kesch C , Rohrich M , Rathke H , Gampp H , Ristau J , Adeberg S , Jager D , Debus J , Haberkorn U , Koerber SA

Ref : Eur J Nucl Med Mol Imaging , 49 :721 , 2022

Abstract :

PubMedSearch : Dendl_2022_Eur.J.Nucl.Med.Mol.Imaging_49_721

PubMedID: 34342669

Title : Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET\/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer - Ristau_2020_Mol.Imaging.Biol_22_1495

Author(s) : Ristau J , Giesel FL , Haefner MF , Staudinger F , Lindner T , Merkel A , Schlittenhardt J , Kratochwil C , Choyke PL , Herfarth K , Debus J , Haberkorn U , Koerber SA

Ref : Mol Imaging Biol , 22 :1495 , 2020

Abstract :

PubMedSearch : Ristau_2020_Mol.Imaging.Biol_22_1495

PubMedID: 33063132

Ristau J

References (2)

1. FAP imaging in rare cancer entities-first clinical experience in a broad spectrum of malignancies - Dendl_2022_Eur.J.Nucl.Med.Mol.Imaging_49_721

2. Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET\/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer - Ristau_2020_Mol.Imaging.Biol_22_1495